Prostate cancer Board decisions

The Board has remanded the issues of service connection for prostate cancer, hepatitis B, and hypertension due to potential exposure to herbicide agents in Vietnam. The Veteran's claims will be further developed.

The Board dismissed all issues related to service connection for hypertension and prostate cancer, as well as the effective date of a disability rating for prostate cancer.

The Board has granted service connection for atherosclerotic cardiovascular disease, diabetes mellitus type II, prostate cancer status post prostatectomy, erectile dysfunction, diabetic nephropathy, and right and left lower extremity peripheral neuropathies. The conditions are presumed to be related to herbicide agent exposure.

The Veteran's claims for service connection are being remanded due to conflicting evidence regarding his claimed former POW status and combat experiences. Additional development is needed, including verifying the Veteran's involvement in special operations incidents and confirming his former POW status.

The Board has decided to remand several claims for further development due to the submission of additional evidence not previously reviewed by the AOJ. The Veteran's increased rating claim for left knee disability, service connection claims for eye disability, joint pain, neck disability, headaches, and prostate cancer are all being remanded.

The Veteran's appeal has been dismissed as he requested withdrawal of the appeal. The Board did not have jurisdiction to review the appeal because it was about a different issue (prostate cancer) than what was originally appealed (PTSD).

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with the requirements under Diagnostic Code 7528.

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with the requirements under Diagnostic Code 7528.

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with all requirements under Diagnostic Code 7528.

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with the requirements under Diagnostic Code 7528.

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with the requirements under Diagnostic Code 7528.

The Veteran's anxiety disorder is rated at 50 percent, effective as of the date of this decision.,The Veteran is granted TDIU based on his service-connected disabilities.

The Veteran's prostate cancer is presumed to be related to his in-service exposure to an herbicide agent while stationed at Korat RTAFB, and the Board has granted service connection for this condition.

The Veteran's service-connected disabilities do not prevent him from obtaining or maintaining a substantially gainful occupation.

The Board has determined that new and relevant evidence has been submitted for the claims of service connection for Type II Diabetes Mellitus, Residuals of Prostate Cancer, Skin Condition, and Peripheral Neuropathy. The Veteran's exposure to herbicide agents in Thailand is now conceded, but further examination is needed to determine the nature and etiology of his skin condition and peripheral neuropathy.

The Board has determined that new and relevant evidence has been submitted for the claims of service connection for Type II Diabetes Mellitus, Residuals of Prostate Cancer, Skin Condition, and Peripheral Neuropathy. The Veteran's exposure to herbicide agents in Thailand is now conceded. The claims are remanded for further examination and opinion regarding the nature and etiology of these conditions.

The Veteran's PTSD is rated at 50 percent, which is the maximum rating available under DC 9411.,The Veteran's prostate cancer is currently rated at 40 percent for voiding dysfunction. The Board has granted a TDIU based on his service-connected disabilities and overall unemployability due to PTSD.,A total disability based on individual unemployability (TDIU) is granted.

The Board has determined that new and relevant evidence has been submitted for the claims of service connection for Type II Diabetes Mellitus, Residuals of Prostate Cancer, Skin Condition, and Peripheral Neuropathy. The Veteran's exposure to herbicide agents in Thailand is now conceded. The claims are remanded for further examination and opinion regarding the nature and etiology of these conditions.

The Veteran's prostate cancer is granted as service connected due to exposure to herbicide agents during his active duty in Thailand. The effective date of the grant will be determined by the AOJ.

The Veteran's claim for an earlier effective date for residuals of bladder cancer is denied as the earliest evidence of a claim was March 14, 2017.,The Veteran's claim for a rating in excess of 20 percent from March 14, 2017 to October 2, 2018 for residuals of bladder cancer with prostate cancer is denied as the symptoms do not warrant such a rating.